Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06649916 · ClinicalTrials.gov registry record · NA

Word Learning From Parentese in Autistic Children

A NA study of Autism Spectrum Disorder and Autism, sponsored by The University of Texas at Dallas.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06649916 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 100 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06649916, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by The University of Texas at Dallas.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).

Interventions

  • BEHAVIORAL Parentese Speech
  • BEHAVIORAL Adult Registered Speech

Study Locations (1)

Texas

  • University of Texas at Dallas - Richardson

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-10-04
Est. Completion 2028-03-01
Phase NA

Sponsor

The University of Texas at Dallas

50 total trials

What the Registry Record Tells You About NCT06649916

The ClinicalTrials.gov registry entry for NCT06649916 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (26% lower). The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Parentese Speech is the first listed.

NCT06649916 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06649916 about?

NCT06649916 is a clinical study titled "Word Learning From Parentese in Autistic Children". The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).

What is the current status of trial NCT06649916?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-04. Estimated completion is 2028-03-01.

What conditions does trial NCT06649916 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Neurodevelopmental Disorders.

What interventions are being tested in trial NCT06649916?

The interventions under investigation include: Parentese Speech (BEHAVIORAL), Adult Registered Speech (BEHAVIORAL).

Who is sponsoring clinical trial NCT06649916?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06649916 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.